SurModics, Inc. (SRDX) Tops Q3 EPS by 4c; Raises FY12 EPS Outlook
Tweet
Share
E-mailGet Alerts SRDX Hot Sheet
Price: $42.98 --0%
Financial Fact:
Total operating costs and expenses: 14.07M
Today's EPS Names:
AFIB, VAXX, NMRD, More
Financial Fact:
Total operating costs and expenses: 14.07M
Today's EPS Names:
AFIB, VAXX, NMRD, More
Join SI Premium – FREE
SurModics, Inc. (NASDAQ: SRDX) reported Q3 EPS of $0.17, $0.04 better than the analyst estimate of $0.13. Revenue for the quarter came in at $14 million versus the consensus estimate of $12.39 million.
SurModics, Inc. sees FY2012 EPS of $0.56-$0.59, versus prior guidance of $0.45-$0.53 and the consensus of $0.53.
For earnings history and earnings-related data on SurModics, Inc. (SRDX) click here.
SurModics, Inc. sees FY2012 EPS of $0.56-$0.59, versus prior guidance of $0.45-$0.53 and the consensus of $0.53.
For earnings history and earnings-related data on SurModics, Inc. (SRDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
- Global Water Resources (GWRS) Tops Q2 EPS by 1c
- Idaho Strategic Resources, Inc. (IDR) Misses Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
